Ho Chi Minh City will struggle to attract private investors if it continues with stringent …
Read More »Poredeen Appoints ICB as Exclusive Named Patient Program Manager for HMTM# in Hong Kong and Macau
“Making TauRx’s groundbreaking drug HMTM# accessible to patients with Alzheimer’s Disease under Named Patient Program” HONG KONG SAR / SINGAPORE – Media OutReach Neswire – 18 January 2024 – ICB Medical Ltd (“ICB“), a member of the Immuno Cure BioTech Group (“Immuno Cure“), is appointed as the exclusive Named Patient …
Read More »